1. Home
  2. VIR vs ARIS Comparison

VIR vs ARIS Comparison

Compare VIR & ARIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ARIS
  • Stock Information
  • Founded
  • VIR 2016
  • ARIS 2015
  • Country
  • VIR United States
  • ARIS United States
  • Employees
  • VIR N/A
  • ARIS N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ARIS Water Supply
  • Sector
  • VIR Health Care
  • ARIS Utilities
  • Exchange
  • VIR Nasdaq
  • ARIS Nasdaq
  • Market Cap
  • VIR 706.4M
  • ARIS 789.3M
  • IPO Year
  • VIR 2019
  • ARIS 2021
  • Fundamental
  • Price
  • VIR $5.63
  • ARIS $24.19
  • Analyst Decision
  • VIR Strong Buy
  • ARIS Buy
  • Analyst Count
  • VIR 11
  • ARIS 7
  • Target Price
  • VIR $25.73
  • ARIS $25.86
  • AVG Volume (30 Days)
  • VIR 1.1M
  • ARIS 1.5M
  • Earning Date
  • VIR 10-30-2025
  • ARIS 11-03-2025
  • Dividend Yield
  • VIR N/A
  • ARIS 2.31%
  • EPS Growth
  • VIR N/A
  • ARIS 11.24
  • EPS
  • VIR N/A
  • ARIS 0.83
  • Revenue
  • VIR $19,000,000.00
  • ARIS $475,504,000.00
  • Revenue This Year
  • VIR N/A
  • ARIS $13.86
  • Revenue Next Year
  • VIR $15.25
  • ARIS $3.78
  • P/E Ratio
  • VIR N/A
  • ARIS $28.98
  • Revenue Growth
  • VIR N/A
  • ARIS 16.42
  • 52 Week Low
  • VIR $4.16
  • ARIS $14.46
  • 52 Week High
  • VIR $14.45
  • ARIS $33.95
  • Technical
  • Relative Strength Index (RSI)
  • VIR 59.22
  • ARIS 50.96
  • Support Level
  • VIR $5.36
  • ARIS $24.14
  • Resistance Level
  • VIR $6.00
  • ARIS $24.85
  • Average True Range (ATR)
  • VIR 0.28
  • ARIS 0.35
  • MACD
  • VIR 0.03
  • ARIS -0.07
  • Stochastic Oscillator
  • VIR 65.62
  • ARIS 30.19

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ARIS Aris Water Solutions Inc.

Aris Water Solutions Inc is an environmental infrastructure and solutions company delivering full-cycle water handling and recycling solutions. Its integrated pipelines and related infrastructure create long-term value by delivering high-capacity, comprehensive produced water management, recycling, and supply solutions to operators in the core areas of the Permian Basin. The company manages its business through a single operating segment comprising two primary revenue streams, Produced Water Handling and Water Solutions. The Produced Water Handling business gathers, transports, and unless recycled, handles produced water generated from oil and natural gas production, and the Water Solutions business develops and operates recycling facilities to treat, store, and recycle produced water.

Share on Social Networks: